AI in Biopharma: No Longer Theoretical

AI Day brings together a Nobel laureate designing proteins from scratch and the scientist who leads drug discovery and development research at Anthropic.

David Baker, director of the Institute for Protein Design at the University of Washington, returns to talk about the progress and challenges as de novo proteins move from the lab toward becoming drugs, and how that could lead to dramatically different types of medicines. Then, in a livestreamed fireside chat, Anthropic's Nathan Frey will discuss the company's latest advances in the life sciences and its vision for the AI future of the drug industry.

Register here.